GRADE 3A FOLLICULAR LYMPHOMA
Clinical trials for GRADE 3A FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRADE 3A FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for GRADE 3A FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to outsmart Tough-to-Treat lymphoma
Disease control Recruiting nowThis study is testing whether combining two drugs, pirtobrutinib and mosunetuzumab, works better for people with follicular lymphoma that has returned or not responded to previous treatments. The goal is to see if this combination can kill more cancer cells and potentially reduce…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Gentler cancer treatment trial seeks to control Slow-Growing lymphoma
Disease control Recruiting nowThis study is testing whether a lower dose of the drug mosunetuzumab can effectively treat slow-growing B-cell lymphomas while potentially reducing side effects. The trial will enroll 20 adults with early-stage, low-tumor-burden lymphoma who haven't had prior treatment. Researche…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New combo therapy aims to control lymphoma, possibly stop treatment after remission
Disease control Recruiting nowThis study is testing a two-drug combination (acalabrutinib and obinutuzumab) for people with untreated, slow-growing non-Hodgkin lymphomas. The goal is to see if this approach can effectively control the cancer, improve quality of life, and determine if patients who achieve a co…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC